QT
CTKB icon

Quantbot Technologies’s Cytek Biosciences CTKB Stock Holding History

Quantbot Technologies’s Portfolio CTKB Stock Details CTKB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$29K Buy
+6,536
New +$27.9K ﹤0.01% 1730
2026
Q1 		– Sell
-38,533
Closed -$195K – 1780
2025
Q4 		$195K Buy
38,533
+4,626
+14% +$21.5K 0.01% 1245
2025
Q3 		$118K Buy
33,907
+9,176
+37% +$34.4K ﹤0.01% 1416
2025
Q2 		$84.1K Buy
+24,731
New +$82.4K ﹤0.01% 1434
2023
Q4 		– Sell
-46,452
Closed -$256K – 1633
2023
Q3 		$256K Buy
+46,452
New +$373K 0.02% 830
2023
Q1 		– Sell
-12,882
Closed -$132K – 1640
2022
Q4 		$132K Buy
+12,882
New +$173K 0.01% 1044

Other funds holding CTKB

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
TCM
Topline Capital Management Santa Monica, California $386M AUM 2.37% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Quantbot Technologies's CTKB Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Cytek Biosciences (CTKB) in Q2 2026: 6,536 shares worth $29K. The stake represents ﹤0.01% of the portfolio and ranks #1730 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in CTKB as recently as Q4 2025.

Quantbot Technologies first reported a position in CTKB in Q4 2022 and has held it in 6 quarters since. The position peaked at $256K in Q3 2023. 155 funds tracked by Wall St. Rank hold CTKB as of Q2 2026.

  • Quantbot Technologies held 6,536 shares of Cytek Biosciences worth $29K as of Q2 2026.
  • Cytek Biosciences was a new Quantbot Technologies position in Q2 2026.
  • Cytek Biosciences made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1730 holding.
  • Quantbot Technologies first reported a position in Cytek Biosciences in Q4 2022 and has held it in 6 quarters since.
  • Quantbot Technologies's Cytek Biosciences position peaked at $256K in Q3 2023.
  • 155 funds tracked by Wall St. Rank held Cytek Biosciences as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.